Feline leukemia viruses (FeLV) are horizontally transmitted oncoretroviruses that are widespread in domestic cat populations and induce both suppressive and neoplastic diseases of the feline lymphoreticular system (19) . The FeLV family consists of three known subgroups, A, B, and C, distinguished by virus and pseudotype interference (reflecting receptor specificity), neutralization, and host-range assays (25, 30, 31, 50) . FeLV-A isolates generally grow only in feline cells, whereas FeLV-B and FeLV-C isolates have an extended host range that includes certain human, canine, and, in the case of FeLV-C, guinea pig cells (23) (24) (25) 51) . Different subgroups of FeLV are associated with distinct diseases, the determinants for which have been mapped to the surface glycoprotein (SU) encoded by the envelope gene (13, 40, 47) . FeLV-A is present in all natural infections, is noncytopathic, and is not acutely pathogenic, giving rise to lymphomas after a long latency (12, 23, 26, 41) . In contrast, some molecularly cloned viruses derived from the FeLV-FAIDS isolate (21, 39) are T-cell cytopathic and cause fatal immunodeficiency disease in cats (43, 44) , although they probably utilize the subgroup A receptor (30, 31) . FeLV-C isolates are rare, utilize a distinct receptor, and induce aplastic anemia (7, 20, 22, 35, 47, 48) . FeLV-B isolates readily arise via recombination between FeLV-A and endogenous FeLV-like elements (45, 57) , are frequently found in natural infections, and are associated with proliferative disease induction (23, 26, 40) . FeLV-B also shares a common cell surface receptor with gibbon ape leukemia virus and simian sarcoma-associated virus as initially concluded from syncytial cross-interference studies (55) and recently confirmed by superinfection interference experiments (59) .
Normally, retrovirus infection results in the down-regulation or surface blockade of its cognate receptor, rendering the cell resistant to superinfection with viruses utilizing the same receptor (11, 14, 56, 65, 66) . However, the mechanism of T-cell killing by FeLV-FAIDS involves massive superinfection of already infected susceptible cells (13) , with FeLV-A isolates differing in their ability to block this super-* Corresponding author.
infection (30) . Some of the same viral genetic changes in the envelope gene responsible for this failure of superinfection resistance have been implicated in disease induction in vivo (13, 46a) . Thus, virus-receptor interactions seem to be critically involved in the pathogenicity of FeLV.
The nature of the cell surface components used by retroviruses as receptors remains undetermined in most cases. However, genes coding for three retrovirus receptors have been identified. A receptor for human immunodeficiency virus is the cell surface protein CD4 (9, 29, 36) , expression of which is required for infection of most cells (29) . CD4 has also been shown to directly bind the human immunodeficiency virus SU protein (2, 34) , and CD4-SU complexes can be immunoprecipitated with noninterfering anti-CD4 monoclonal antibodies (MAbs) (38) . Genes encoding receptors for the ecotropic murine leukemia virus (MuLV) (1) and gibbon ape leukemia virus (42) have also been identified. Expression of these genes renders certain nonpermissive cells susceptible to infection and capable of binding viral surface glycoprotein (1, 28, 42, 64) . Recently, Takeuchi et al. (59) have found that noninfectible mouse cells can become susceptible to infection with FeLV-B after they acquire the human gene for the gibbon ape leukemia virus receptor. In addition, several proteins have been identified on murine cell surfaces which bind MuLV (8, 10, 49, 62) ; however, the relationship of these to each other and their function as MuLV receptors remain to be determined.
We took a biochemical approach to the identification of a receptor for FeLV-A on the feline T-cell line 3201 (FeT). We purified the SU protein from a molecularly cloned representative of FeLV-A (clone 61E from the FeLV-FAIDS in 1:1 L15-RPMI medium (GIBCO) supplemented with 20% fetal calf serum, penicillin, streptomycin, and L-glutamine.
The human T-lymphoma cell line HuT78 (17) and the feline embryo fibroblast (FeF) cell line AH927 (originated by W.
Nelson-Rees and provided by S. Rasheed) were cultured in RPMI 1640 medium and Dulbecco modified Eagle medium, respectively, both with 10% fetal calf serum and supplemented as described above. Molecularly cloned subgroup A FeLV (isolate 61E) (12, 43) was transfected into FeF cells and grown in large volumes in Spinner flasks at the Massachusetts Institute of Technology cell culture facility. Tenliter batches of culture supernatant were harvested, clarified by centrifugation (10,000 x g for 10 min), and concentrated to about 300 ml by ultrafiltration (Amicon). The concentrated virus preparation was stored in 1-ml aliquots in liquid nitrogen.
MAb preparation. A mouse hybridoma cell line that secretes the MAb C11D8 was a gift from C. K. Grant and was grown in RPMI 1640 medium with 10% fetal calf serum supplemented as described above. It is a broadly neutralizing antibody that recognizes a linear epitope in a constant region of FeLV envelope protein (15, 18) . MAb was purified from 500 ml of culture supernatant by filtration (0.45-,um pore) and then protein A-Sepharose chromatography (2 ml)
at a flow rate of 0.5 ml/min at 4°C (3 8 .0], 0.14 M NaCl, 0.0025% sodium azide, 0.1% Triton X-100, 0.1% deoxycholate, 1 mM phenylmethylsulfonyl fluoride) at 4°C for 2 h, and insoluble material was removed by centrifugation (4,000 x g for 10 min). C11D8 was coupled to cyanogen bromide-activated Sepharose 4B (Pharmacia) according to the manufacturer's instructions (2.5 mg of MAb per ml of Sepharose). Detergent-solubilized virus was mixed with 2 ml of antibody-Sepharose (preequilibrated with TSA buffer) for 3 h at 4°C and then poured into a chromatography column. The column was washed with 10 volumes of TSA and 5 volumes of sodium phosphate buffer (50 mM sodium phosphate [pH 6.3] , 0.1% Triton X-100, 0.5 M NaCl) to remove nonspecifically bound material. Bound gp7O was eluted with 5 volumes of 50 mM glycine-0.15 M NaCl (pH 2.5). Eluted gp7O was neutralized with 0.1 volume of 1 M Tris (pH 9.0), desalted by dialysis against 5 mM ammonium bicarbonate at 4°C for 24 h, and then concentrated by lyophilization and stored at -80°C.
The purity and integrity of gp7O was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by the method of Laemmli (33) . After electrophoresis, the gel was fixed in 50% methanol in water and then silver stained (Stratagene). Purified gp7O was labeled with 125I by the Enzymobead lactoperoxidase reaction (BioRad) according to the manufacturer's instructions. Unincorporated iodine was removed by two successive rounds of size exclusion chromatography (Bio-Rad Bio-Gel P-6-DG column). An aliquot of labeled gp7O was precipitated with 10% trichloroacetic acid at 4°C for 1 h and centrifuged, and the radioactivity of the pellet was counted to determine the trichloroacetic acid-precipitable radioactivity. An aliquot of gp7O was also analyzed by SDS-PAGE on a 10% gel. After electrophoresis, the gel was fixed with 30% methanol-10% acetic acid for 30 (27) . Cells were washed twice in reaction buffer (PBS [pH 7.41 containing 55 mM glucose, 1 mM CaCl2, 1 mg of bovine serum albumin (BSA) per ml, and 1% nonfat dry milk) and then resuspended in 0.3 ml of reaction buffer containing 5 x 104 cells. 125I-labeled gp7O (2.5 to 160 ng, 2 x 104 cpm/ng) in 0.1 ml of reaction buffer was added, and the cells were incubated at room temperature (24°C) for 2 h with rotation. At the end of incubation, the cells were collected on filter discs presoaked in 100% fetal calf serum for 1 h to prevent nonspecific adsorption (cellulose acetate; 0.45-,m pore size; 25-mm diameter; Millipore) and washed with 20 ml of ice-cold reaction buffer. Filters were dried, and bound radioactivity was determined in a gamma scintillation counter. Nonspecific binding to FeT cells was estimated from the radioactivity bound to HuT78, and specific binding to FeT cells was calculated by subtracting the amount bound to HuT78 cells.
Cross-linking studies. After incubation of FeT cells with 125I-labeled gp7O in 1 ml of reaction buffer as described above, cells were harvested by centrifugation at 400 x g for 10 min, and unbound gp7O present in the supernatant was removed. Cells were then resuspended in 1 ml of PBS (pH (ii) Cell membranes. After 1251 labeling, plasma membranes were isolated by sucrose density gradient centrifugation by the method of Maeda et al. (37) . FeT or HuT78 cells were washed twice with 10 mM Tris-saline (pH 7.5), resuspended in homogenization buffer (10 mM sodium phosphate [pH 7.4] containing 1 mM MgCl2, 30 mM NaCl, 0.005 mM phenylmethylsulfonyl fluoride, and 0.02% sodium azide) at a cell concentration of 3 x 107/ml, and then homogenized in a loose-fitting Dounce homogenizer, using 20 to 25 strokes for cell disruption (monitored under a light microscope). About 25 ml of the homogenate was layered over 10 ml of 41% sucrose in homogenization buffer and centrifuged at 95,000 x g for 1 h in a Beckman SW27 swinging-bucket rotor. A white interface band of enriched membrane was collected, sucrose was diluted by adding a two-to threefold excess of homogenization buffer, and membranes were pelleted by centrifugation at 95,000 x g for 20 min. Membranes were washed twice and used immediately or stored at -80°C until used. Protein concentration was determined by the method of Bradford (5) with bovine gamma globulin as the standard. Coprecipitation of labeled cell membrane with gp7O was then performed as described above.
RESULTS Purification and binding of FeLV envelope glycoprotein (gp7O) to FeT cells. The gp7O used in the present study was purified from a detergent-solubilized concentrated virus preparation by immunoaffinity chromatography with the anti-gp7O MAb, C11D8. A single major band of protein of 70 kDa was observed after electrophoresis and silver staining (Fig. IA, lane 2) . After 1251 labeling, a major band of 70 kDa was found along with two minor bands (46 and 32 kDa) (Fig.   1B ). About 80% of the radioactivity from 125I-labeled gp7O could be precipitated with 10% trichloroacetic acid, and the final specific radioactivity of iodinated gp7O was 1.5 x 104 to 2 x 104 cpm/ng of protein.
Binding of 125I-labeled gp7O to cells grown in the log phase was measured, and saturation of cellular binding sites was or approximately 1.4 x 10-14 mol ( Fig. 2A) . Under the same conditions, a small linearly increasing amount of gp7O was found to bind HuT78 cells, which we considered to be nonspecific. The amount of gp7O bound to HuT78 cells was subtracted from the amount bound to FeT cells to determine the specific binding to FeT cells (Fig. 2B, inset) . The specificity of gp7O binding to FeT cells was further demonstrated through viral interference. The saturation level of gp7O binding was reduced to 44% when FeT cells chronically infected with FeLV-A were used (data not shown). Scatchard analysis (52) of saturation binding curves shown in Table 1) .
Identification of putative gp7O-receptor complex. Affinity cross-linking has been used to investigate the interaction of various peptide hormones, growth factors, and their receptors (32, 46, 53, 58, 67) as well as the interaction of human immunodeficiency virus and CD4+ T cells (38) . In this study, we used the homobifunctional cross-linking reagents DSS (noncleavable) and DSP (cleavable under reducing conditions) to detect membrane components that interact with gp7O. FeT cells and HuT78 cells were incubated with 1251_ labeled gp7O, and then DSS or DSP was added to covalently VOL. 66, 1992 on (Fig. 3, lane f) compared with uninfected cells, consistent with the reduced availability of receptor described above. To address the possibility that the 135-to 140-kDa cross-linked band resulted from dimerization of gp7O, we performed the experiment under the same conditions using 1 I-labeled gp7O and incubation in the absence of cells. Under these conditions, no cross-linked band was detected (Fig. 3, lane g ). When examined under reducing conditions, the DSScross-linked band was retained, whereas the DSP-crosslinked band disappeared, indicating dissociation of the gp7O-receptor complex. These experiments indicate that gp7O binds to a protein on the FeT cell surface having a molecular mass of approximately 65 to 70 kDa.
Immunoprecipitation of DSS-crosslinked 125I-gp7O and cell lysates with the anti-gp7O MAb, C11D8, also revealed a 135-to 140-kDa band (Fig. 4, lane b) in addition to gp7O. In contrast, parallel immunoprecipitation of HuT78 cell lysates failed to reveal any bands above the size of gp7O (Fig. 4, lane  e) . Because of the large quantity of BSA present in these binding experiments, we included antibody to BSA as an additional control in immunoprecipitations. No radiolabeled bands were visible when anti-BSA antibody was used (Fig.  4, lane d) , indicating that the 135-to 140-kDa band did not result from cross-linking of '25I-labeled gp7O to BSA. In addition, nonimmune mouse immunoglobulin G2b (same subclass as C11D8) did not precipitate a detectable band (Fig. 4, lane c) . Last, the detectable level of the cross-linked band was reduced in virus-infected cells (Fig. 4, lane g) . Thus, the 135-to 140-kDa band appears to result from formation of a specific complex between gp7O and its putative receptor.
Coprecipitation of 70-kDa cell surface molecule with gp7O.
To directly identify the cell surface molecule that binds gp7O, cells were surface labeled with 125J by the glucose oxidaselactoperoxidase technique (as described in Materials and Methods). Subsequently, these labeled cells were incubated with or without unlabeled gp7O for 2 h in binding buffer, unbound gp7O was removed by washing, and a detergent lysate of the cells was immunoprecipitated with the anti-gp7O MAb, C11D8 (Fig. 5) . A single band with a molecular mass of approximately 70 kDa was found to coprecipitate from FeT cells in the presence of gp7O (Fig. 5, lane b) but not in the absence of gp7O (Fig. 5, lane c) . Incubation of cells with 10 mM EDTA prevented the coprecipitation of the 70-kDa cell membrane protein (Fig. 5, lane d) . Also, no such band with a similar molecular mass was coprecipitated from HuT78 cells either in the presence (Fig. 5 , lane e) or in the absence (Fig. 5 , lane f) of gp7O. To rule out the possibility that some free 1251 may have been trapped on the cell or carried over in the reaction mixture, resulting in transfer of label to gp7O, we prepared membranes from labeled cells on sucrose density gradients. The labeled membranes were then incubated with unlabeled gp7O and immunoprecipitated with C11D8 (Fig. 6) . The results were identical to that seen with intact cells: a 70-kDa protein band was coprecipitated in the presence (Fig. 6, lane b) but not in the absence (Fig. 6 , lane c) of gp70. (30) .
The failure of the neutralizing MAb C11D8 (which binds to a constant region near the center of gp7O) (15) to prevent receptor binding suggests that sequences involving the C11D8 epitope are involved in a postattachment phase of viral entry. The region of gp7O imparting A and C subgroup specificity, in contrast, is found near the N terminus of gp7O (7) . The characterization of a cellular receptor for FeLV and subsequent glycoprotein-receptor interactions may therefore (10 ,ug) . After solubilization of membranes, lysates were immunoprecipitated with 30 ,ug of anti-gp7O MAb (C11D8) and analyzed as described in the legend to Fig. 5 . Lane d is a membrane lysate. Lane a is "4C-labeled molecular mass markers. The arrow indicates the position of the putative receptor.
